Eisai
4523.T
#2013
Rank
โ‚น690.63 B
Marketcap
โ‚น2,450
Share price
3.80%
Change (1 day)
-37.71%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น188.43. In 2022 the company made an earnings per share (EPS) of โ‚น138.33 a decrease over its 2021 EPS that were of โ‚น614.11.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6029.84%
2022โ‚น138.33-77.48%
2021โ‚น614.11-41.88%
2020โ‚น1,057-0.94%
2019โ‚น1,06752.59%
2018โ‚น699.00124.17%
2017โ‚น311.82-49.42%
2016โ‚น616.5437.08%
2015โ‚น449.78-11.75%
2014โ‚น509.64-3.23%
2013โ‚น526.65-18.56%
2012โ‚น646.71-15.51%
2011โ‚น765.46-3.75%
2010โ‚น795.32-1.36%
2009โ‚น806.27